Title: 

1. A Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer  

2. Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia

Moderator: Ari Hakimian,DO - PGY 4 Hem/Onc Fellow, Lutheran General Hospital

Session date: 
10/17/2024 - 7:30am to 8:30am CDT
Location: 
Sasser Conference Room
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
    Attendance Credit

Please login or register to take this course.